Literature DB >> 24870768

Multicenter analysis of gestational trophoblastic neoplasia in Turkey.

Sabit Sinan Ozalp1, Elcin Telli, Tufan Oge, Gokhan Tulunay, Nurettin Boran, Taner Turan, Mufit Yenen, Zehra Kurdoglu, Ali Ozler, Kunter Yuce, Volkan Ulker, Macit Arvas, Fuat Demirkiran, Tugan Bese, Nedim Tokgozoglu, Anil Onan, Muzaffer Sanci, Mehmet Gokcu, Gokhan Tosun, Yilmaz Dikmen, Aydin Ozsaran, Mustafa Cosan Terek, Levent Akman, Hakan Yetimalar, Derya Sakarya Kilic, Tayfun Gungor, Emre Ozgu, Yunus Yildiz, Arif Kokcu, Mehmet Kefeli, Serkan Kuruoglu, Hasan Yuksel, Tevfik Guvenal, Pinar Solmaz Hasdemir, Bulent Ozcelik, Serdar Serin, Mehmet Dolanbay, Dagistan Tolga Arioz, Nadire Tuncer, Hasan Bozkaya, Suleyman Guven, Deniz Kulaksiz, Fusun Varol, Ali Yanik, Gonca Ogurlu, Tayyup Simsek, Tayfun Toptas, Selen Dogan, Hakan Camuzoglu, Murat Api, Kadir Guzin, Eray Caliskan, Emek Doger, Bulent Cakmak, Tolgay Tuyan Ilhan.   

Abstract

BACKGROUND: To evaluate the incidence, diagnosis and management of GTN among 28 centers in Turkey.
MATERIALS AND METHODS: A retrospective study was designed to include GTN patients attending 28 centers in the 10-year period between January 2003 and May 2013. Demographical characteristics of the patients, histopathological diagnosis, the International Federation of Gynecology and Obstetrics (FIGO) anatomical and prognostic scores, use of single-agent and multi-agent chemotherapy, surgical interventions and prognosis were evaluated.
RESULTS: From 2003-2013, there were 1,173,235 deliveries and 456 GTN cases at the 28 centers. The incidence was calculated to be 0.38 per 1,000 deliveries. According to the evaluated data of 364 patients, the median age at diagnosis was 31 years (range, 15-59 years). A histopathological diagnosis was present for 45.1% of the patients, and invasive mole, choriocarcinoma and PSTTs were diagnosed in 22.3% (n=81), 18.1% (n=66) and 4.7% (n=17) of the patients, respectively. Regarding final prognosis, 352 (96.7%) of the patients had remission, and 7 (1.9%) had persistence, whereas the disease was mortal for 5 (1.4%) of the patients.
CONCLUSIONS: Because of the differences between countries, it is important to provide national registration systems and special clinics for the accurate diagnosis and treatment of GTN.

Entities:  

Mesh:

Year:  2014        PMID: 24870768     DOI: 10.7314/apjcp.2014.15.8.3625

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  Investigation of Risk Factors, Stage and Outcome in Patients with Gestational Trophoblastic Disease since 2001 to 2011 in Iran-Yazd.

Authors:  Mojgan Karimi-Zarchi; Mohammad Reza Mortazavizadeh; Malihe Soltani-Gerdefaramrzi; Mitra Rouhi; Pouria Yazdian-Anari; Mohammad Hosain Ahmadiyeh
Journal:  Int J Biomed Sci       Date:  2015-12

2.  Giant invasive mole presenting as a cause of abdominopelvic mass in a perimenopausal woman: An unusual presentation of a rare pathology.

Authors:  Alpaslan Akyol; Memet Şimşek; Özlem Üçer
Journal:  Obstet Gynecol Sci       Date:  2016-11-15

Review 3.  A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors.

Authors:  Xuan Feng; Zhi Wei; Sai Zhang; Yan Du; Hongbo Zhao
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

4.  Diagnostic challenge of perimenopause molar pregnancy in a 52-year-old lady: Case report.

Authors:  Willbroad Kyejo; Davis Rubagumya; Gregory Ntiyakuze; Nancy Matillya; Munawar Kaguta; Miriam Mgonja; Lynn Moshi
Journal:  Int J Surg Case Rep       Date:  2022-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.